Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.

Fujii S, Shimizu K, Hemmi H, Steinman RM.

Immunol Rev. 2007 Dec;220:183-98. Review.

PMID:
17979847
2.

Regulation of immune responses by CD1d-restricted natural killer T cells.

Van Kaer L.

Immunol Res. 2004;30(2):139-53. Review.

PMID:
15477656
3.

Application of natural killer T cells in antitumor immunotherapy.

Hong C, Park SH.

Crit Rev Immunol. 2007;27(6):511-25. Review.

PMID:
18197797
4.

Natural killer T cell-mediated antitumor immune responses and their clinical applications.

Seino K, Motohashi S, Fujisawa T, Nakayama T, Taniguchi M.

Cancer Sci. 2006 Sep;97(9):807-12. Epub 2006 Jun 29. Review.

5.

Natural-killer cells and dendritic cells: "l'union fait la force".

Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E.

Blood. 2005 Oct 1;106(7):2252-8. Epub 2005 Jun 2. Review.

6.

Dendritic cells in innate immune responses against HIV.

Servet C, Zitvogel L, Hosmalin A.

Curr Mol Med. 2002 Dec;2(8):739-56. Review.

PMID:
12462394
7.

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.

PMID:
16197336
8.

Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.

Wilson MT, Van Kaer L.

Curr Pharm Des. 2003;9(3):201-20. Review.

PMID:
12570826
9.

Natural killer T cells as targets for immunotherapy of autoimmune diseases.

Van Kaer L.

Immunol Cell Biol. 2004 Jun;82(3):315-22. Review.

10.

NKT cells - conductors of tumor immunity?

Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI.

Curr Opin Immunol. 2002 Apr;14(2):165-71. Review.

PMID:
11869887
11.

Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.

Godó M, Sessler T, Hamar P.

Curr Med Chem. 2008;15(18):1778-87. Review.

PMID:
18691038
12.

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.

Wu L, Gabriel CL, Parekh VV, Van Kaer L.

Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Epub 2009 Apr 8. Review.

PMID:
19392798
13.

Killer dendritic cells and their potential role in immunotherapy.

Ullrich E, Chaput N, Zitvogel L.

Horm Metab Res. 2008 Feb;40(2):75-81. doi: 10.1055/s-2007-1022554. Review.

PMID:
18283624
14.

Application of natural killer T-cells to posttransplantation immunotherapy.

Fujii S.

Int J Hematol. 2005 Jan;81(1):1-5. Review.

PMID:
15717680
15.

iNKT-cell responses to glycolipids.

Parekh VV, Wilson MT, Van Kaer L.

Crit Rev Immunol. 2005;25(3):183-213. Review.

PMID:
16048435
16.

Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.

Fujii S.

Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Review.

PMID:
18372215
17.

Natural killer T cells and autoimmune disease.

Wu L, Van Kaer L.

Curr Mol Med. 2009 Feb;9(1):4-14. Review.

PMID:
19199937
18.

[Dendritic cells and tumor specific immunity].

Takahashi H.

Gan To Kagaku Ryoho. 1999 Dec;26(14):2121-6. Review. Japanese.

PMID:
10635293
19.

Natural killer cells and dendritic cells: rendezvous in abused tissues.

Moretta A.

Nat Rev Immunol. 2002 Dec;2(12):957-64. Review.

PMID:
12461568
20.

Glycolipids as immune modulatory tools.

Lalazar G, Preston S, Zigmond E, Ben Yáacov A, Ilan Y.

Mini Rev Med Chem. 2006 Nov;6(11):1249-53. Review.

PMID:
17100636

Supplemental Content

Support Center